Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells.

par Katie Matthews, Nancy P Y Chung, Per Johan Klasse, Magda Moutaftsi, Darrick Carter, André M Salazar, Steven G Reed, Rogier W Sanders, John P Moore
Publié 2013-01-01